Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
DBV Technologies
Biotech
DBV peanut allergy patch hits endpoint in phase 3 infant study
DBV chalked up a win for its beleaguered peanut allergy patch candidate, hitting the primary endpoint in a phase 3 clinical trial in infants.
Nick Paul Taylor
Jun 8, 2022 8:40am
DBV preps 200 layoffs after nasty FDA reaction to peanut patch
Jan 7, 2021 11:18am
FDA turns back DBV Technologies' peanut allergy patch for kids
Aug 4, 2020 12:28pm
FDA chief Scott Gottlieb steps down—Chutes & Ladders
Mar 8, 2019 9:00am
DBV loses regulatory, R&D execs ahead of peanut drug refile
Mar 6, 2019 9:46am
DBV CMO leaves as peanut allergy player rejigs team
Jan 3, 2019 9:50am